ANGIOINSIGHT, INC.
AI software platform using computational modeling and machine learning to non-invasively estimate Fractional Flow Reserve (FFR) for coronary artery disease diagnosis and treatment planning
- Sector
- Digital health
- Headquarters
- ANN ARBOR, MI
- Total capital
- $256K
- Federal grants
- $256K
- 1 award · 2022
- Rank in peer group#17 of 42
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 9 pending · first 2026
- Rank in peer group#3 of 42
Capital timeline
Latest events
- Federal grantNSF · Phase I · STTR Phase I:Feasibility Study of a Reduced Order Model for Calculating Fractional Flow Reserve (FFR) Using Angiographic Data$256K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 42 peers
Line = medianDigital health · Software
- Federal grants#17 · top 40%
- Granted patents#3 · top 7%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 10- GrantedAnatomical And Functional Assessment Of Coronary Artery Disease Using Machine LearningUSPTOUS 12,670,603
- PendingGraphical User Interface for Flow Rate Extraction from Angiographic InformationUSPTOApplication 18892184
- PendingData-driven-based Analysis Of Coronary Index Of Microcirculatory Resistance From Angiography DataUSPTOApplication 19230677
Show all 10 patent records
- Anatomical And Functional Assessment Of Coronary Artery Disease Using Machine LearningJun 30, 2026 · US 12,670,603Granted
- Graphical User Interface for Flow Rate Extraction from Angiographic InformationMar 26, 2026 · Application 18892184Pending
- Data-driven-based Analysis Of Coronary Index Of Microcirculatory Resistance From Angiography DataDec 11, 2025 · Application 19230677Pending
- Flow Rate Extraction From Angiographic ImagesNov 27, 2025 · Application 19216264Pending
- Flow Rate Extraction From Angiographic InformationApplication 63697235Pending
- Data-Driven-Based Analysis of Coronary Index of Microcirculatory Resistance from Angiography DataApplication 63657767Pending
- Graphical user interface for flow rate extraction from angiographic informationApplication 63697415Pending
- Graphical User Interface For Display Of Flow Rate Extracted From Angiographic InformationApplication PCTUS2025047115Pending
- Flow Rate Extraction From Angiographic InformationApplication PCTUS2025030624Pending
- Physics Informed Neural Network For Assessing HemodynamicsApplication PCTUS2025060598Pending
Related companies, and why
- NURELM, INC.Similar federal contract value in Digital health · null in contracts
- HOMININ.AI INC.Similar federal contract value in Digital health · null in contracts
- TAO Connect, Inc.Similar federal contract value in Digital health · null in contracts
- CAPSICOHEALTH, INC.Similar federal contract value in Digital health · null in contracts
- BIOMEDICAL DEVELOPMENT CORPSimilar federal contract value in Digital health · null in contracts
- CURII CORPSimilar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .